Insider Transactions in Q4 2021 at T Scan Therapeutics, Inc. (TCRX)

TCRX Quotes by TradingView

Insider Transaction List (Q4 2021)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Dec 23 2021
David P Southwell Chief Executive Officer
BUY
Exercise of conversion of derivative security
Direct
48,670 +24.93%
$48,670 $1.97 P/Share

Track Institutional and Insider Activities on TCRX

Follow TScan Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRX shares.

Notify only if

Insider Trading

Get notified when an T Scan Therapeutics, Inc. insider buys or sells TCRX shares.

Notify only if

News

Receive news related to TScan Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRX